Your browser doesn't support javascript.
loading
Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL.
Kameda, Kazuaki; Kako, Shinichi; Kim, Sung-Won; Usui, Yoshiaki; Kato, Koji; Fukuda, Takahiro; Uchida, Naoyuki; Kobayashi, Hikaru; Wakayama, Toshio; Sakaida, Emiko; Yano, Shingo; Imada, Kazunori; Nara, Miho; Ikeda, Takashi; Fuchida, Shin-Ichi; Ishikawa, Jun; Sugahara, Hiroyuki; Kanda, Junya; Kimura, Takafumi; Ichinohe, Tatsuo; Atsuta, Yoshiko; Kondo, Eisei.
Afiliação
  • Kameda K; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. kamedakazuaki@jichi.ac.jp.
  • Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Kim SW; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Usui Y; Division of Cancer Information and Control, Department of Preventive Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Kato K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
  • Kobayashi H; Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan.
  • Wakayama T; Department of Hematology and Oncology, Shimane Prefectural Central Hospital, Izumo, Japan.
  • Sakaida E; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Yano S; Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan.
  • Imada K; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
  • Nara M; Division of Hematology, Nephrology and Rheumatology, Akita University Hospital, Akita, Japan.
  • Ikeda T; Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan.
  • Fuchida SI; Department of Hematology, Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
  • Ishikawa J; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
  • Sugahara H; Department of Hematology, Sumitomo Hospital, Osaka, Japan.
  • Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kimura T; Preparation Department, Japanese Red Cross Kinki Block Blood Center, Osaka, Japan.
  • Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Kondo E; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
Leukemia ; 36(5): 1361-1370, 2022 05.
Article em En | MEDLINE | ID: mdl-35347237

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / Transplante de Células-Tronco Hematopoéticas / Linfadenopatia Imunoblástica Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / Transplante de Células-Tronco Hematopoéticas / Linfadenopatia Imunoblástica Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão